Search details
1.
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.
Blood
; 136(25): 2881-2892, 2020 12 17.
Article
in English
| MEDLINE | ID: mdl-33113551
2.
Multi-national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome.
Transfusion
; 62(7): 1355-1364, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35686926
3.
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
J Natl Compr Canc Netw
; 20(6): 635-642.e9, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35714676
4.
Addressing Barriers to Reducing Prescribing and Implementing Deprescribing of Sedative-Hypnotics in Primary Care.
Ann Pharmacother
; 56(4): 463-474, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34301151
5.
COVID-19 and blood cancer in the vaccination era.
Blood
; 140(26): 2763-2765, 2022 12 29.
Article
in English
| MEDLINE | ID: mdl-36580343
6.
COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis.
Am J Hematol
; 97(4): E132-E135, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35007350
7.
Nutrient Insufficiencies/Deficiencies in Children With Sickle Cell Disease and Its Association With Increased Disease Severity.
Pediatr Blood Cancer
; 63(6): 1060-4, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-26855061
8.
Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients.
Pediatr Blood Cancer
; 60(10): 1671-5, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23776184
9.
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell Lymphoma.
J Clin Oncol
; 41(8): 1577-1589, 2023 03 10.
Article
in English
| MEDLINE | ID: mdl-36315922
10.
Antibody-drug conjugates: in search of partners of choice.
Trends Cancer
; 9(4): 339-354, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36746689
11.
Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience.
JCO Oncol Pract
; 19(5): e672-e682, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36821811
12.
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer.
J Natl Cancer Inst
; 115(2): 146-154, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36321960
13.
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies.
Am Soc Clin Oncol Educ Book
; 43: e390778, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37163714
14.
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
JAMA Oncol
; 9(3): 386-394, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36580318
15.
Benchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospital.
Pain Res Manag
; 17(4): 291-6, 2012.
Article
in English
| MEDLINE | ID: mdl-22891195
16.
Exploring therapeutic alliance with an internet-based self-management program with brief telephone support for youth with arthritis: a pilot study.
Telemed J E Health
; 18(4): 271-6, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22424081
17.
The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review.
Curr Oncol
; 29(2): 892-900, 2022 02 07.
Article
in English
| MEDLINE | ID: mdl-35200575
18.
Reply to: Vitamin insufficiencies/deficiencies in relation to sickle cell disease severity and associated morbidity.
Pediatr Blood Cancer
; 63(12): 2250-2251, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27392202
19.
The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis.
Inflammopharmacology
; 19(1): 21-34, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21076878
20.
Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy.
Bone Marrow Transplant
; 56(10): 2400-2409, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33986499